Headline from Sierra World Equity today: Potential Acquisition Coming To YM BioSciences (YMI) After Sale Of Assets Relating To Nimotuzumab Predicts Sierra World Equity Review
Man I wish Sierra knew what she was talking about. She sure is some fine eye candy though.
Good Catch, we'll see what happens
Correction - next action to be divestiture of cyt387 to allow YMI to focus 100% on Glover's compensation plan.